<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33386850</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1759-4685</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of molecular cell biology</Title><ISOAbbreviation>J Mol Cell Biol</ISOAbbreviation></Journal><ArticleTitle>Haploinsufficiency of the TDP43 ubiquitin E3 ligase RNF220 leads to ALS-like motor neuron defects in the mouse.</ArticleTitle><Pagination><StartPage>374</StartPage><EndPage>382</EndPage><MedlinePgn>374-382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jmcb/mjaa072</ELocationID><Abstract><AbstractText>TDP43 pathology is seen in a large majority of amyotrophic lateral sclerosis (ALS) cases, suggesting a central pathogenic role of this regulatory protein. Clarifying the molecular mechanism controlling TDP43 stability and subcellular location might provide important insights into ALS therapy. The ubiquitin E3 ligase RNF220 is involved in different neural developmental processes through various molecular targets in the mouse. Here, we report that the RNF220+/- mice showed progressively decreasing mobility to different extents, some of which developed typical ALS pathological characteristics in spinal motor neurons, including TDP43 cytoplasmic accumulation, atrocytosis, muscle denervation, and atrophy. Mechanistically, RNF220 interacts with TDP43 in vitro and in vivo and promotes its polyubiquitination and proteasomal degradation. In conclusion, we propose that RNF220 might be a modifier of TDP43 function in vivo and contribute to TDP43 pathology in neurodegenerative disease like ALS.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2021). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, CEMCS, CAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Pengcheng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming 650203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huishan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming 650203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Bingyu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming 650223, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Mol Cell Biol</MedlineTA><NlmUniqueID>101503669</NlmUniqueID><ISSNLinking>1759-4685</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014452">Ubiquitins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C548734">RNF220 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057895" MajorTopicYN="N">Haploinsufficiency</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014452" MajorTopicYN="N">Ubiquitins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNF220</Keyword><Keyword MajorTopicYN="N">TDP43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">polyubiquitination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>2</Day><Hour>12</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33386850</ArticleId><ArticleId IdType="pmc">PMC8373269</ArticleId><ArticleId IdType="doi">10.1093/jmcb/mjaa072</ArticleId><ArticleId IdType="pii">6059226</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmeti K.B., Ajroud-Driss S., Al-Chalabi A., et al. (2012). Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. Neurobiol. Aging 34, 357.e7&#x2013;357.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839234</ArticleId><ArticleId IdType="pubmed">22959728</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold H.C., Jackson K.L., Arora A., et al. (2018). TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep. 8, 4606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Finkbeiner S. (2010). Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways. Rev. Neurosci. 21, 251&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">21086759</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Serio A., Arjun A., et al. (2014). Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 10, 677&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chio A., Traynor B.J. (2018). Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 17, 94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammer E.B., Fallini C., Gozal Y.M., et al. (2012). Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM2 Ubiquitination. PLoS One 7, e38658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3380899</ArticleId><ArticleId IdType="pubmed">22761693</ArticleId></ArticleIdList></Reference><Reference><Citation>Dion P.A., Daoud H., Rouleau G.A. (2009). Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat. Rev. Genet. 10, 769&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pubmed">19823194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebstein S.Y., Yagudayeva I., Shneider N.A. (2019). Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a TARDBP Knockin mouse model of ALS. Cell Rep. 26, e364&#x2013;e373.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625319</ArticleId></ArticleIdList></Reference><Reference><Citation>Galves M., Rathi R., Prag G., et al. (2019). Ubiquitin signaling and degradation of aggregate-prone proteins. Trends BiochemSci. 44, 872&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">31079890</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N., Menon P., Ozdinler P.H., et al. (2016). Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat. Rev. Neurol. 12, 651&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F., Lee V.M., Trojanowski J.Q. (2010). Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology 30, 103&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3131978</ArticleId><ArticleId IdType="pubmed">20102519</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., et al. (2017). Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers 3, 17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebron M.L., Lonskaya I., Sharpe K., et al. (2013). Parkinubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J. Biol. Chem. 288, 4103&#x2013;4115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3567661</ArticleId><ArticleId IdType="pubmed">23258539</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill S.J., Mordes D.A., Cameron L.A., et al. (2016). Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc. Natl Acad. Sci. USA 113, E7701&#x2013;E7709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Choi T.I., Park S., et al. (2018). Rnf220 cooperates with Zc4h2 to specify spinal progenitor domains. Development 145, dev165340.</Citation><ArticleIdList><ArticleId IdType="pubmed">30177510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Q., Zeng W., Wu J., et al. (2010). RNF220, an E3 ubiquitin ligase that targets Sin3B for ubiquitination. Biochem. Biophys. Res. Commun. 393, 708&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">20170641</ArticleId></ArticleIdList></Reference><Reference><Citation>Le N.T., Chang L., Kovlyagina I., et al. (2016). Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proc. Natl Acad. Sci. USA 113, E7580&#x2013;E7589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127348</ArticleId><ArticleId IdType="pubmed">27834214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.B., Lee V.M., Trojanowski J.Q. (2012). Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 13, 38&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.C., Huang W.C., Lin J.H., et al. (2018). Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43-ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology. J. Biomed. Sci. 25, 76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6223059</ArticleId><ArticleId IdType="pubmed">30404641</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Yokoshi M., Okada H., et al. (2015). The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity. Nat. Commun. 6, 6183.</Citation><ArticleIdList><ArticleId IdType="pubmed">25630387</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P., An T., Zhu L., et al. (2020a). RNF220 is required for cerebellum development and regulates medulloblastoma progression through epigenetic modulation of Shh signaling. Development 147, dev188078.</Citation><ArticleIdList><ArticleId IdType="pubmed">32376680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P., Song N.N., Cheng X., et al. (2020b). ZC4H2 stabilizes RNF220 to pattern ventral spinal cord through modulating Shh/Gli signaling. J. Mol. Cell Biol. 12, 337&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7288745</ArticleId><ArticleId IdType="pubmed">31336385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P., Song N.N., Li Y., et al. (2019). Fine-tuning of Shh/Gli signaling gradient by non-proteolytic ubiquitination during neural patterning. Cell Rep. 28, 541&#x2013;553.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">31291587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P., Yang X., Kong Q., et al. (2014). The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of &#x3b2;-catenin. Mol. Cell. Biol. 34, 4355&#x2013;4366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4248747</ArticleId><ArticleId IdType="pubmed">25266658</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R., Neumann M. (2010). TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9, 995&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Vance C., Nishimura A.L., et al. (2014). Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 127, 1263&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Song N.N., Ma P., Zhang Q., et al. (2020). Rnf220/Zc4h2-mediated monoubiquitinatylation of Phox2 is required for noradrenergic neuron development. Development 147, dev185199.</Citation><ArticleIdList><ArticleId IdType="pubmed">32094113</ArticleId></ArticleIdList></Reference><Reference><Citation>Swatek K.N., Komander D. (2016). Ubiquitin modifications. Cell Res. 26, 399&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4822133</ArticleId><ArticleId IdType="pubmed">27012465</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. (2014). The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 10, 661&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashiro Y., Urushitani M., Inoue H., et al. (2012). Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J. Biol. Chem. 287, 42984&#x2013;42994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522293</ArticleId><ArticleId IdType="pubmed">23095749</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. (2016). Decoding ALS: from genes to mechanism. Nature 539, 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Sato T., Bamba H., et al. (2010). Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J. Neurosci. Res. 88, 784&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19798749</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., Shatunov A., Dekker A.M., et al. (2016). Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 48, 1043&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., et al. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 106, 18809&#x2013;18814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Hideyama T., Hachiga K., et al. (2012). A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat. Commun. 3, 1307.</Citation><ArticleIdList><ArticleId IdType="pubmed">23250437</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P., Guo X., Yang W., et al. (2019). Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains. Acta Neuropathol. 137, 919&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531422</ArticleId><ArticleId IdType="pubmed">30810811</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Ye M., Zhu L., et al. (2020). Loss of ZC4H2 and RNF220 inhibits neural stem cell proliferation and promotes neuronal differentiation. Cells 9, 1600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7408363</ArticleId><ArticleId IdType="pubmed">32630355</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>